Author(s): Chakraverty R, Orti G, Roughton M, Shen J, Fielding A, Kottaridis P, Milligan D, Collin M, Crawley C, Johnson P, Clark A, Parker A, Bloor A, Pettengell R, Snowden J, Pettitt A, Clark R, Hale G, Peggs K, Thomson K, Morris E, Mackinnon S
Keywords: Chronic lymphocytic leukemia; Versus-host-disease; Population pharmacokinetics; Alloceneic transplantation; Cytomegalovirus infection; Adoptive immunotherapy; T cells; Campath-1H; Regimen; Antibodies
|
Professor Matthew Collin
|
|